Abstract
Transcatheter aortic valve replacement (TAVI) has become a game changer in the management of severe aortic stenosis shifting the concept from inoperable or high-risk patients to intermediate or low surgical-risk individuals. Among devices available nowadays, there is no clear evidence that one device is better than the other or that one device is suitable for all patients. The selection of the optimal TAVI valve for every patient represents a challenging process for clinicians, given a large number of currently available devices. Consequently, understanding the advantages and disadvantages of each valve and personalising the valve selection based on patient-specific clinical and anatomical characteristics is paramount. This review article aims to both analyse the available devices in the presence of specific clinical and anatomic features and offer guidance to select the most suitable valve for a given patient.
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference126 articles.
1. 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease;Eur. Heart J.,2022
2. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation,2021
3. Principles of TAVR Valve Design, Modelling, and Testing;Expert Rev. Med. Devices,2018
4. Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function;JACC Cardiovasc. Imaging,2019
5. Comparison of Latest Generation Supra-Annular and Intra-Annular Self-Expanding Transcatheter Heart Valves;J. Thorac. Dis.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献